Joshua Kazam

Joshua Kazam

Founder at KRONOS BIO, INC.

Net worth: 2 M $ as of 2024-03-30

47 year
Finance
Health Technology
Technology Services

Profile

Mr. Joshua A. Kazam is an Independent Director at Soaring Eagle Acquisition Corp., an Independent Director at Tishman Speyer Innovation Corp. II, an Independent Director at TS Innovation Acquisitions Corp., a Director & Partner at Vida Ventures LLC, a Partner at Two River Consulting LLC, a Director & Co-Owner at Riverbank Capital Securities, Inc., a Co-Founder & Partner at Two River Group Holdings LLC, a Co-Founder at VV Manager LLC, a Director & Vice President at Two River Group Management LLC, a Member-Executive Board at The Wharton School of the University of Pennsylvania and a Principal at BCIF Pty Ltd. He is on the Board of Directors at Soaring Eagle Acquisition Corp., Tishman Speyer Innovation Corp. II, TS Innovation Acquisitions Corp., Breakthrough Properties LLC, Breakthrough Services LLC, Allogene Therapeutics, Inc., Vida Ventures LLC, Kronos Bio, Inc., ByHeart, Inc., Desert Flower Foundation GmbH, Vision Path, Inc., MedPod, Inc., Veterinary Prime, Inc., Riverbank Capital Securities, Inc., 105 W First Street LLC, Cortiva Therapy, Danube Pharmaceuticals, Inc., Kirax Corp., Tranzutary Holdings LLC, Vetprime, Inc. and Two River Group Management LLC. Mr. Kazam was previously employed as an Independent Director by Flying Eagle Acquisition Corp., an Independent Director by Diamond Eagle Acquisition Corp., an Independent Director by Platinum Eagle Acquisition Corp., an Independent Director by Capricor Therapeutics, Inc., a Director-Investment Management by Orion Biomedical Fund LP, a Managing Director by Paramount BioCapital, Inc., and a Chief Executive Officer & Director by IconOVir Bio, Inc. He also served on the board at Kite Pharma, Inc., Velcera, Inc., Arno Therapeutics, Inc., Nile Therapeutics, Inc. /Old/, Arno Therapeutics, Inc. /Old/, Manhattan Pharmaceuticals, Inc. and Velcera Pharmaceuticals, Inc. /Old/. He received his undergraduate degree from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-06-12 303,063 ( 0.18% ) 1 M $ 2024-03-30
2023-06-21 366,503 ( 0.61% ) 476 454 $ 2024-03-30

Joshua Kazam active positions

CompaniesPositionStart
TISHMAN SPEYER INNOVATION CORP. II Director/Board Member 2021-02-10
SCREAMING EAGLE ACQUISITION CORP. Director/Board Member 2022-01-04
KRONOS BIO, INC. Founder 2017-06-01
ALLOGENE THERAPEUTICS, INC. Founder 2017-10-31
The Wharton School of the University of Pennsylvania Corporate Officer/Principal -
Director/Board Member 2019-03-31
Founder -
Founder 2016-10-31
Breakthrough Services LLC Director/Board Member 2019-03-31
░░░░░░░░ ░░░░ ░░░░ ░░░░░░░ -
░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
All active positions of Joshua Kazam

Former positions of Joshua Kazam

CompaniesPositionEnd
░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Joshua Kazam's experience

Training of Joshua Kazam

The Wharton School of the University of Pennsylvania Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joshua Kazam's experience

Connections

100 +

1st degree connections

42

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies6
TG THERAPEUTICS, INC.

Health Technology

ARNO THERAPEUTICS, INC.

Health Technology

ALLOGENE THERAPEUTICS, INC.

Health Technology

KRONOS BIO, INC.

Health Technology

SCREAMING EAGLE ACQUISITION CORP.

Finance

CAPRICOR THERAPEUTICS, INC.

Health Technology

Private companies35

Finance

Finance

Health Technology

Finance

Health Technology

Arno Therapeutics, Inc. /Old/

Health Technology

Technology Services

Orion Biomedical Fund LP

Velcera Pharmaceuticals, Inc. /Old/

Health Technology

Nile Therapeutics, Inc. /Old/

Health Technology

Health Technology

Cortiva Therapy

Health Technology

Tranzutary Holdings LLC

Consumer Non-Durables

Vetprime, Inc.

Distribution Services

Desert Flower Foundation GmbH

Finance

Finance

Finance

Finance

Commercial Services

Finance

Finance

Finance

Finance

Breakthrough Services LLC

Finance

Finance

Health Technology

Finance

Finance

Finance

Health Technology

See company connections